Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices.
Volpara Health Technologies Limited is a research, development, and manufacturing company based in Wellington, New Zealand. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trade marks, we apply science to the solving of clinical problems around the world.
Volpara Health Technologies Limited holds certification to ISO27001 and ISO13485; MDSAP 690110 certification for Japan, Australia, Canada, and the United States; and is a US FDA–registered establishment whose products are listed accordingly. In addition, our products hold CE Marking under European Medical Device Directive 93/42/EEC. Volpara Solutions Limited is our wholly owned sales and marketing subsidiary.
To reduce the mortality and cost of breast cancer by providing clinically-validated software that underpins personalized, high-quality breast cancer screening.